These data show a strong upregulation of AKT3 in AML samples carrying a mutated RUNX1 gene, but in contrast a downregulation in samples harboring the RUNX1-RUNX1T1 translocation. This evidence concerns the gene RUNX1 and acute myeloid leukemia.